A detailed history of Global Retirement Partners, LLC transactions in Cassava Sciences Inc stock. As of the latest transaction made, Global Retirement Partners, LLC holds 2,200 shares of SAVA stock, worth $61,864. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,200
Holding current value
$61,864
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

BUY
$12.35 - $26.11 $27,170 - $57,442
2,200 New
2,200 $27,000
Q1 2022

Jul 14, 2022

BUY
$32.6 - $53.05 $16,300 - $26,525
500 New
500 $13,000
Q4 2021

Jan 21, 2022

SELL
$36.77 - $90.91 $18,385 - $45,455
-500 Closed
0 $0
Q2 2021

Jul 15, 2021

BUY
$32.15 - $89.72 $16,075 - $44,860
500 New
500 $43,000

Others Institutions Holding SAVA

About CASSAVA SCIENCES INC


  • Ticker SAVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,097,900
  • Market Cap $1.13B
  • Description
  • Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...
More about SAVA
Track This Portfolio

Track Global Retirement Partners, LLC Portfolio

Follow Global Retirement Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Retirement Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Global Retirement Partners, LLC with notifications on news.